Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
NeoImmune NMTNT110
Clinical Trial Grant
Duke Scholars
Principal Investigator
Christopher Hoimes
Medicine, Medical Oncology
Administered By
Duke Cancer Institute
Awarded By
NeoImmuneTech, Inc.
Start Date
August 7, 2020
End Date
July 30, 2025
Administered By
Duke Cancer Institute
Awarded By
NeoImmuneTech, Inc.
Start Date
August 7, 2020
End Date
July 30, 2025
